[{"orgOrder":0,"company":"Iperboreal Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"ITALY","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Ribitol","moa":"Glycosylation||Xylose isomerase; Xylose isomerase; Xylose isomerase; Xylose isomerase; Hyaluronate lyase","graph1":"Nephrology","graph2":"Phase II","graph3":"Iperboreal Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Iperboreal Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Iperboreal Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Iperboreal Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"ITALY","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Icodextrin","moa":"Undisclosed","graph1":"Nephrology","graph2":"Phase II","graph3":"Iperboreal Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Solution","sponsorNew":"Iperboreal Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Iperboreal Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Iperboreal Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"ITALY","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Polydextrin","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase I\/ Phase II","graph3":"Iperboreal Pharma","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Solution","sponsorNew":"Iperboreal Pharma \/ Undisclosed","highestDevelopmentStatusID":"7","companyTruncated":"Iperboreal Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Iperboreal Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"ITALY","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Xylocore","moa":"Undisclosed","graph1":"Nephrology","graph2":"Phase III","graph3":"Iperboreal Pharma","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Iperboreal Pharma \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"Iperboreal Pharma \/ Undisclosed"}]